Though several studies demonstrated a role for EGFR-dependent signaling in cardiac hypertrophy and EGFR inhibitors attenuated organ deterioration [60,61,62], our findings indicate that systemic EGF and EGFR display no specificity for PH and RVH. Here, EGF is linked to cardiac hypertrophy.